155 related articles for article (PubMed ID: 35153976)
1. T2 FLAIR Hyperintensity Volume Is Associated With Cognitive Function and Quality of Life in Clinically Stable Patients With Lower Grade Gliomas.
Luks TL; Villanueva-Meyer JE; Weyer-Jamora C; Gehring K; Jakary A; Hervey-Jumper SL; Braunstein SE; Bracci PM; Brie MS; Smith EM; Chang SM; Taylor JW
Front Neurol; 2021; 12():769345. PubMed ID: 35153976
[TBL] [Abstract][Full Text] [Related]
2. Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.
Nam YK; Park JE; Park SY; Lee M; Kim M; Nam SJ; Kim HS
Eur Radiol; 2021 Oct; 31(10):7374-7385. PubMed ID: 34374800
[TBL] [Abstract][Full Text] [Related]
3. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase.
Avalos LN; Luks TL; Gleason T; Damasceno P; Li Y; Lupo JM; Phillips J; Oberheim Bush NA; Taylor JW; Chang SM; Villanueva-Meyer JE
Neurooncol Adv; 2022; 4(1):vdac175. PubMed ID: 36479058
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.
Corell A; Ferreyra Vega S; Hoefling N; Carstam L; Smits A; Olsson Bontell T; Björkman-Burtscher IM; Carén H; Jakola AS
BMC Cancer; 2020 May; 20(1):450. PubMed ID: 32434559
[TBL] [Abstract][Full Text] [Related]
6. Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for
Kinoshita M; Arita H; Takahashi M; Uda T; Fukai J; Ishibashi K; Kijima N; Hirayama R; Sakai M; Arisawa A; Takahashi H; Nakanishi K; Kagawa N; Ichimura K; Kanemura Y; Narita Y; Kishima H
Front Oncol; 2020; 10():596448. PubMed ID: 33520709
[TBL] [Abstract][Full Text] [Related]
7. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
8. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
[TBL] [Abstract][Full Text] [Related]
9. MR textural analysis on T
Rui W; Ren Y; Wang Y; Gao X; Xu X; Yao Z
J Magn Reson Imaging; 2018 Jul; 48(1):74-83. PubMed ID: 29140606
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impact of lower-grade gliomas and strategies for rehabilitation.
Weyer-Jamora C; Brie MS; Luks TL; Smith EM; Braunstein SE; Villanueva-Meyer JE; Bracci PM; Chang S; Hervey-Jumper SL; Taylor JW
Neurooncol Pract; 2021 Apr; 8(2):117-128. PubMed ID: 33898046
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in
Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH
AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas.
Deguchi S; Oishi T; Mitsuya K; Kakuda Y; Endo M; Sugino T; Hayashi N
Sci Rep; 2020 Jun; 10(1):10113. PubMed ID: 32572107
[TBL] [Abstract][Full Text] [Related]
14. The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.
Yeniçeri İÖ; Yıldız ME; Özduman K; Danyeli AE; Pamir MN; Dinçer A
Diagn Interv Radiol; 2021 Nov; 27(6):796-801. PubMed ID: 34792037
[TBL] [Abstract][Full Text] [Related]
15. Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.
Patel SH; Bansal AG; Young EB; Batchala PP; Patrie JT; Lopes MB; Jain R; Fadul CE; Schiff D
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1149-1155. PubMed ID: 31248860
[TBL] [Abstract][Full Text] [Related]
16. The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis.
Park SI; Suh CH; Guenette JP; Huang RY; Kim HS
Eur Radiol; 2021 Jul; 31(7):5289-5299. PubMed ID: 33409784
[TBL] [Abstract][Full Text] [Related]
17. T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.
Patel SH; Poisson LM; Brat DJ; Zhou Y; Cooper L; Snuderl M; Thomas C; Franceschi AM; Griffith B; Flanders AE; Golfinos JG; Chi AS; Jain R
Clin Cancer Res; 2017 Oct; 23(20):6078-6085. PubMed ID: 28751449
[No Abstract] [Full Text] [Related]
18. Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas.
Stall B; Zach L; Ning H; Ondos J; Arora B; Shankavaram U; Miller RW; Citrin D; Camphausen K
Radiat Oncol; 2010 Jan; 5():5. PubMed ID: 20109218
[TBL] [Abstract][Full Text] [Related]
19. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
Pirzkall A; Nelson SJ; McKnight TR; Takahashi MM; Li X; Graves EE; Verhey LJ; Wara WW; Larson DA; Sneed PK
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1254-64. PubMed ID: 12128127
[TBL] [Abstract][Full Text] [Related]
20. Isocitrate Dehydrogenase, Patient-Reported Outcomes, and Cognitive Functioning of Glioma Patients: a Systematic Review.
Bunevicius A; Miller J; Parsons M
Curr Oncol Rep; 2020 Sep; 22(12):120. PubMed ID: 32965568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
